MFT / LCSW

Behavioral Interventions for Migraine Prevention

5.00 - CE credit hours training

$25.00 - Cost of course

This page contains important information about the course, including training details, a comprehensive course description, learning objectives, and source references. We encourage you to review each section to gain a clear understanding of the course content, educational goals, and supporting materials before beginning your training and taking the POST TEST below.

Target audience and instructional level of this course: foundational
There is no known conflict of interest or commercial support related to this CE program.

Behavioral Interventions for Migraine Prevention

30 Questions

1. The strength of evidence for the effectiveness of behavioral interventions in migraine prevention is generally described as:
2. What is the main limitation regarding the evidence on adverse effects of behavioral interventions for migraine?
3. Compared to education alone, mindfulness-based stress reduction (MBSR) in adults may offer greater benefit in terms of:
4. The study's inclusion criteria specified trials conducted in countries rated as:
5. In children and adolescents, which combination of interventions showed promise in reducing migraine frequency and disability?
6. The majority of studies focused on patients with which type of migraine?
7. The study's findings regarding the effectiveness of individual behavioral components are:
8. The meta-analysis on the effect of CBT on migraine-specific quality of life (MSQOL) in adults yielded:
9. In adults with chronic migraine, what intervention showed potential for reducing headache frequency?
10. What is a significant limitation of many studies included in this systematic review?
11. What was the primary focus of this systematic review?
12. What was the average headache frequency at baseline for adolescents in the included studies?
13. The most common components of behavioral treatments used in the reviewed trials were:
14. What is a primary concern regarding the control groups used in many of the included studies?
15. Which of the following is NOT a limitation mentioned in the study regarding the implementation of behavioral interventions?
16. In the meta-analysis of CBT for adults, what was the effect on migraine/headache attack frequency?
17. In the meta-analysis of CBT for adults, what was the effect on migraine-related disability?
18. In the meta-analysis of biofeedback for adults, the effect on migraine/headache attack frequency was:
19. What was the most common reason for excluding studies during the full-text review phase of the systematic review?
20. What did the study find regarding the impact of adding a behavioral component to an existing behavioral treatment?
21. Which of the following was a common finding related to the reporting of adverse events in the included studies?
22. The review included studies from which countries?
23. What was the main focus of Key Question 1 in the systematic review?
24. A significant challenge in analyzing the effectiveness of specific behavioral components stemmed from:
25. What was the most common reason for high risk of bias judgements in the KQ1 studies?
26. The study's search strategy included:
27. The meta-analysis of biofeedback for adults showed what effect on migraine/headache attack frequency?
28. In the studies that included CBT for adults, what other outcomes were frequently reported?
29. What was the overall conclusion regarding the effectiveness of behavioral interventions for migraine prevention?
30. What is a key recommendation for future research on behavioral interventions for migraine?
This article reviews the effectiveness of behavioral interventions, including CBT, biofeedback, relaxation training, and mindfulness-based therapies, for migraine prevention in adults and adolescents. It highlights modest benefits in reducing migraine frequency and disability, with limited evidence for pediatric populations. Mindfulness-based stress reduction may enhance quality of life compared to education, while behavioral sleep modification shows potential for chronic migraines. Adverse effects are rarely reported, and evidence for individual components is inconclusive due to study limitations. The review emphasizes the need for standardized methodologies and further research to evaluate behavioral strategies alongside pharmacologic treatments for migraine management.
  1. Define and describe the role of behavioral interventions, such as CBT, biofeedback, and relaxation training, in reducing migraine frequency and disability.
    Outline and summarize the comparative effectiveness of mindfulness-based stress reduction and other behavioral therapies versus pharmacologic treatments for migraine prevention.
  2. Identify the limitations and gaps in the existing evidence on behavioral interventions for migraines, particularly in pediatric and adolescent populations.
  3. Describe the potential benefits of integrating biopsychosocial factors into migraine prevention strategies and their implications for future research.
    ECRI-Penn Evidence-based Practice Center Plymouth Meeting, PA, and Philadelphia, PA
    Investigators: Jonathan R. Treadwell, Ph.D.a Amy Y. Tsou, M.D.a Benjamin Rouse, M.S.a Ilya Ivlev, M.D., Ph.D.a Julie Fricke, Ph.D.b Dawn Buse, Ph.D.c Scott W. Powers, Ph.D.d,e,f Mia Minen, M.D.g Christina L. Szperka, M.D., M.S.C.E.h Nikhil K. Mull, M.D.b,i
    ECRI, Plymouth Meeting, PA
    Penn Medicine Center for Evidence-based Practice, Philadelphia, PA
    Department of Neurology, Albert Einstein College of Medicine, New York, NY
    Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH
    Headache Center, Cincinnati Children's Hospital, Cincinnati, OH
    Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital, Cincinnati, OH
    New York University Departments of Neurology and Population Health, NYU Langone Health, New York, NY
    Children's Hospital of Philadelphia & Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
    Division of Hospital Medicine, University of Pennsylvania, Philadelphia, PA